Clinical Trials for Platinum-Resistant Fallopian Tube Carcinoma

Find clinical trials for platinum-resistant fallopian tube carcinoma. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

NCT ID: NCT05538091

This clinical trial is looking at a new treatment approach for women with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. These types of cancer are considered "platinum-re...

Recruiting

Phase: PHASE2 Type: interventional Locations: Pittsburgh, Pennsylvania, United States

ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

NCT ID: NCT04055649

This clinical trial is studying a combination of two treatments, ONC201 and paclitaxel, to see how effective they are for women with certain types of ovarian cancer that have not responded well to ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Flint, Michigan, United States

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

NCT ID: NCT06730347

This clinical trial is studying a new treatment called lorigerlimab for women with certain types of advanced cancers, specifically those that are resistant to platinum-based chemotherapy. The trial...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of, Los Angeles, California, United States +16 more

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a and 2) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.

NCT ID: NCT05271318

This clinical trial, called TILT-123, is investigating a new treatment for women with certain types of ovarian cancer that have not responded to standard chemotherapy (known as platinum-resistant o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Helsinki, , Finland +3 more

PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

NCT ID: NCT05465941

This clinical trial is studying a new treatment called PLX038 for patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has become resistant to a common ch...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

NCT ID: NCT06483048

This clinical trial is studying a new treatment approach for women with certain types of ovarian cancer that have returned after treatment or did not respond to previous therapies. The treatment in...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions